Liquid versus foam sclerotherapy

Phlebology

Volumn 24, Issue 6, 2009, Pages 240-246

  Hamel Desnos, C ^a   Allaert, F A ^b  

^a Saint Martin Private Hospital   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Foam sclerotherapy; Liquid sclerotherapy; Saphenous vein; Varices; Varicose veins

Indexed keywords

POLIDOCANOL; TETRADECYL SULFATE SODIUM;

ARTICLE; CLINICAL TRIAL; DYSESTHESIA; ECHOGRAPHY; FOAM; HUMAN; INJECTION SITE REACTION; LEG VARICOSIS; LIQUID; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SAPHENOUS VEIN; SCLEROTHERAPY; SKIN ALLERGY; SKIN NECROSIS; SYSTEMATIC REVIEW; TASTE DISORDER; TELANGIECTASIA; THROMBOSIS; VISUAL DISORDER;

DOSAGE FORMS; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SOLUTIONS; TELANGIECTASIS; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS; VENOUS INSUFFICIENCY; VISION DISORDERS;

EID: 72149091427     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009047     Document Type: Article

References (17)

1. Khale B, Leng K. Efficacy of sclerotherapy in varicose veins - a prospective, blinded, placebo-controlled study. Dermatol Surg 2004;30:723-728 (Pubitemid 38657963)
2. Demagny A. Etude comparative de l'efficacité d'un produit sclérosant sous ses formes liquide ou mousse dans la sclérose échoguidée des crosses des grandes et petites veines saphènes. Phlébologie 2002;55:133-137
3. Belcaro G, Cesarone MR, Di Renzo A, et al. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003;54:307-315 (Pubitemid 36578462)
4. Raymond-Martimbeau P. A randomized clinical trial comparing the sclerosing and side effects of foam versus liquid formula for sclerotherapy of primary varicose veins. In: American College of Phlebology. Syllabus & Scientific Abstracts of the UIP World Congress Chapter Meeting. 27-31 August 2003, San Diego, CA, 2003:138
5. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-1175 (Pubitemid 38009913)
6. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomized controlled trial with a two-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-370
7. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-722 (Pubitemid 38657962)
8. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-245 (Pubitemid 351163086)
9. Tessari L. Nouvelle technique d'obtention de la scléromousse. Phlébologie 2000;53:129
10. Benigni J-P, Sadoun S, Thirion V, Sica M, Demagny A, Chahim M. Télangiectasies et varices réticulaires. Traitement par la mousse d'Aetoxisclérol à 0.25%. Présentation d'une étude pilote. Phlébologie 1999;52:283-290
11. Kern P, Ramelet A-A, Wutschert R, Bounameaux H, Hayoz D. Single-blind randomized study comparing chromate glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins. Dermatol Surg 2004;30:367-372 (Pubitemid 38524153)
12. Alos J, Carreno P, Lopez JA, Estadella B, Serra Prat M, MarinelIo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107 (Pubitemid 43024991)
13. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-936 (Pubitemid 47236534)
14. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate mid-term complications of sclerotherapy. Report of prospective multi-center registry of 12173 sclerotherapy sessions. Dermatol Surg 2005;31:123-128
15. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lausecker M. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:131-138
16. Kern P, Ramelet AA, Wutschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg 2007;45:1212-1216 (Pubitemid 46817846)
17. Hamel-Desnos C, Guias B, Quéhé P, et al. Foam sclerotherapy of saphenous veins with or without medical-support stocking (compression). Biological effects of foam sclerotherapy. Randomized controlled study. Phlebology 2008;23:230-248